Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy
Authors:
- 8 April 2021
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 30 (9) , 2573-2579
Abstract
Purpose Even treated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) continues to pose a significant burden in patients’ everyday functioning and may continuously affect their quality of life (QoL). The aims of our prospective study were to analyze health-related QoL in CIDP patients during a 1-year follow-up period in real-life settings and to compare QoL changes with changes in disability and with patient impression of change. Methods The study comprised 59 patients diagnosed with CIDP. SF-36 questionnaire was applied in order to evaluate patients’ QoL. Inflammatory neuropathy cause and treatment (INCAT) disability scale was used to assess patients’ functionality. The second question from the SF-36 questionnaire was used as an estimation of the patient impression of change (PIC) after 1 year. Results SF-36 scores did not change over time in the group as a whole. According to INCAT disability scores, worsening was registered in 24 (40%) patients and improvement in 8 (14%). Fifteen (25%) patients reported worsening and the same number reported improvement, according to PIC. Concordant results on INCAT and PIC were registered in 49% of patients. Pooled SF-36 scores moderately correlated with pooled INCAT disability scores (rho = − 0.27 to − 0.59, p < 0.01). One-year changes of SF-36 scores did not differ when compared to different INCAT outcomes (worsening, stable, improvement). On the other hand, significant changes of SF-36 scores in different outcome groups according to PIC (worsening, stable, improvement) were noted (p < 0.01). Conclusion INCAT, PIC, and SF-36 are complementary outcome measures that provide neurologists with useful items of information. We propose complementary use of these scales in CIDP patients in everyday clinical practice in order to detect worsening of the disease and/or of related symptoms on time.Keywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (175083)
This publication has 21 references indexed in Scilit:
- Incat disability score: A critical analysis of its measurement propertiesMuscle & Nerve, 2014
- Pain intensity and distribution in chronic inflammatory demyelinating polyneuropathyMuscle & Nerve, 2012
- Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevanceJournal of Neurology, Neurosurgery & Psychiatry, 2010
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First RevisionEuropean Journal of Neurology, 2010
- Health-related quality-of-life improvements in CIDP with immune globulin IV 10%Neurology, 2009
- Disability and health status in patients with chronic inflammatory demyelinating polyneuropathyDisability and Rehabilitation, 2009
- Muscle performance relates to physical function and quality of life in long‐term chronic inflammatory demyelinating polyradiculoneuropathyJournal of the Peripheral Nervous System, 2008
- Functional health status of patients with chronic inflammatory neuropathiesJournal of the Peripheral Nervous System, 2005
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960